Caution: JavaScript execution is disabled in your browser or for this website. You may not be able to answer all questions in this survey. Please, verify your browser parameters.

BOBBi Site Feasibility Questionnaire

Please review the trial summary and complete the questionnaire about the feasibility of running BOBBi at your site.  

Study name Better Outcomes in Babies with Bacterial meningitis, a randomised controlled trial: BOBBi
Study (short) title BOBBi
Sponsor City St George's University of London
Clinical Trials Unit National Perinatal Epidemiology Unit CTU
Population Babies from 32+0 corrected gestational weeks+days up to and including 3 months’ corrected age at randomisation, with suspected bacterial meningitis.
Intervention Steroid (dexamethasone) to treat suspected bacterial meningitis, in addition to treatment-as-usual based on NICE guidelines
Comparator Treatment-as-usual based on NICE guidelines (No Dexamethasone)
Outcomes Survival without moderate or severe neurodevelopmental impairment at 24 months of age corrected for prematurity
Inclusion Criteria
  • Babies from 32+0 corrected gestational weeks+days (at randomisation) up to and including 3 months’ corrected age
  • Suspected or confirmed bacterial meningitis based on having one or more of the following three clinical and/or laboratory features
    1. Seizures or bulging fontanelle or altered consciousness (coma) where bacterial meningitis is suspected
    2. Suspected bacterial meningitis based on having one or more of the following three clinical and/or laboratory features:
      • raised cerebrospinal fluid (CSF) white cell count (>20/mm3 for neonates ≤28 days post birth; >5/mm3 for babies > 28 days post birth)
      • CSF protein ≥0.8g/L
      • ​​​CSF/blood glucose ratio <0.5
    3. Positive CSF Gram stain OR positive CSF polymerase chain reaction (PCR) OR culture for a relevant bacterium
Exclusion criteria
  • First dose of antibiotic for suspected/confirmed meningitis administered more than 12 hours prior to planned administration of dexamethasone
  • Preterm baby less than 34 gestational weeks at birth who is within the first 7 days after birth
  • Previous neurosurgical intervention or shunt
  • Major congenital anomaly
  • Known hypersensitivity to dexamethasone or any of its excipients
  • Previous randomisation into this trial
  • No realistic chance of survival
Consent model deferred consent model will be used. Babies with a diagnosis of suspected bacterial meningitis will be randomised when they meet the above criteria. Informed consent will subsequently be sought for ongoing trial participation and data collection.
Recruitment Babies will be recruited from neonatal units (NNU), paediatric emergency departments (PED), paediatric assessment units (PAU), paediatric intensive care units (PICU) and paediatric wards (PW). It is expected that each site will include 2 or more units (e.g. NNU and PW)
Planned recruitment start date & length 4.5 year recruitment period, planned start date 01 June 2026
Sample size 965
Proposed number of sites 60, with recruitment across 2 or more departments

 

If you have any questions, please email bobbi@npeu.ox.ac.uk 

Site-specific Information

Please share as much information as you can for now, don't worry if some sections are missing, this can be provided later by emailing bobbi@npeu.ox.ac.uk

Name of NHS Trust
Name of Hospital
Principal Investigator details:
We are aiming for two or more departments at your site to be open to recruitment. We anticipate there will be an overall Principal Investigator (PI) for the NHS Trust with Co-PIs for each department/unit. A Co-PI does not necessarily need to be a medically trained doctor, please contact us if you have any queries.
Which department is the PI based in?
How many of the following beds/cots do you have at your hospital?

How many babies aged from 32+0 corrected gestational weeks+days up to and including 3 months' corrected age with proven bacterial meningitis do you care for annually?

You can provide overall or by department
  • per year
  • per year
Has this trial been discussed with your colleagues and is there a unit willingness to participate in the trial?
Yes No Not discussed
Neonatal Unit
Paediatric Emergency Department
Paediatric Assessment Unit
Paediatric Intensive Care Unit
Paediatric Ward
Would an annual target of around 4-5 babies be feasible for your NHS trust?
Please note if this target is not feasible for your site, you will still be considered.
Do you or your colleagues (doctors/nurses) envisage any major barriers to recruiting to this trial?
If yes, please provide further information
Do you routinely follow up infants with bacterial meningitis at your hospital?
If yes, please provide further information (hospital, clinic, age for recall, assessment measures):
Is your microbiology laboratory on site or elsewhere?
If elsewhere, please clarify:
Do you routinely perform PCR on CSF samples?

PCR = Polymerase chain reaction CSF = Cerebrospinal fluid 

If yes, which test do you use?
If yes, how long does it typically take for CSF sample results to be available?
If possible, please estimate the number of CSF samples from babies <3 months' of corrected age routinely processed by your lab?
You can provide by month or by year
Do you routinely follow the NICE neonatal infection and NICE meningitis guidelines with regard to management of bacterial meningitis, including empiric antibiotic choice?
If no, do you follow a local guideline? Please provide a link or upload a copy.
You can upload here:
  Title Comment File name

Is there existing dedicated research infrastructure at your site? i.e. nurse or midwife funding/RDN funding

The study will provide full training and support to sites. The study will provide funding for NHS research activity at sites and will be adopted on the NIHR portfolio to receive funding via accruals.
If yes, please provide further information
Please specify your network of hospitals you routinely transfer babies out to (continuing care sites)
Please list all sites:
Apart from English, what are the top three spoken languages at your site?
Other key contacts:

Please include details (names & email addresses) for Co-PIs, research nurses and other key contacts for each department participating.

If you enter other key contact, please state their role.

  Neonatal Unit Paediatric Assessment Unit Paediatric Intensive Care Unit Paediatric Ward
Co-Principal Investigator(s)
Lead Research Nurse(s)
Other key contact(s) e.g. R&D
Is there anything else that you would like to tell us?
Name and email address of person completing this form: